Why would fibromyalgia patients have osteoporosis?

PubWeight™: 0.94‹?›

🔗 View Article (PMID 10914876)

Published in J Rheumatol on July 01, 2000

Authors

P H Dessein, A E Stanwix

Articles cited by this

Fibromyalgia: a risk factor for osteoporosis. J Rheumatol (1999) 1.63

Articles by these authors

Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis (2000) 1.52

Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis. Rheumatology (Oxford) (1999) 1.43

Rheumatoid arthritis--will better understanding of its pathogenesis lead to better treatment? S Afr Med J (1992) 1.38

Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med (1992) 1.22

Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol (2008) 1.20

High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol (2008) 1.18

Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis. Clin Exp Rheumatol (2009) 1.17

Antibody to HTLV-I in a black South African with a neurological disorder resembling multiple sclerosis. S Afr Med J (1989) 0.90

Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis. Ann Rheum Dis (2008) 0.89

Autonomic neuropathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry (1988) 0.89

More on autonomic neuropathy in systemic sclerosis. Ann Rheum Dis (1988) 0.88

Rheumatoid arthritis and cardiovascular disease may share similar risk factors. Rheumatology (Oxford) (2001) 0.88

Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain (1999) 0.86

Treatment of Raynaud's phenomenon with large doses of triiodothyronine: a pilot study. Ann Rheum Dis (1987) 0.82

Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis. Clin Exp Rheumatol (2009) 0.82

Anticardiolipin antibody negative occlusive vascular retinopathy in systemic lupus erythematosus. Ann Rheum Dis (1990) 0.78

Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis. Arthritis Res (2001) 0.78

Neuroendocrine deficiency-mediated development and persistence of pain in fibromyalgia: a promising paradigm? Pain (2000) 0.77

Burden of depressive symptoms in South African public healthcare patients with established rheumatoid arthritis: a case-control study. Clin Exp Rheumatol (2011) 0.76

Multiple sclerosis, tropical spastic paraparesis and HTLV-I infection. J Neurol Neurosurg Psychiatry (1992) 0.75

Hydrocortisone and chronic fatigue syndrome. Lancet (1999) 0.75

Treatment of Raynaud's phenomenon with triiodothyronine corrects co-existent autonomic dysfunction: preliminary findings. Postgrad Med J (1992) 0.75

Autonomic dysfunction in systemic sclerosis: the site of damage. Ann Rheum Dis (1989) 0.75

Antiphospholipid antibodies in South Africa blacks with connective tissue diseases--more evidence for an 'aPL-negative coagulopathy'? S Afr Med J (1993) 0.75

Tri-iodothyronine in Raynaud's phenomenon: further objective evidence of its beneficial effect. Br J Rheumatol (1988) 0.75

[OP.2B.04] CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION-DERIVED GLOMERULAR FILTRATION RATE IS BETTER AT DETECTING PRE-CLINICAL END ORGAN CHANGES THAN OTHER EQUATIONS IN BLACK AFRICANS. J Hypertens (2016) 0.75

SLE in black S. Africans. Br J Rheumatol (1988) 0.75

Systemic sclerosis: another disease with autonomic dysfunction. Ann Neurol (1988) 0.75